ATRA vs FAST · rev $128.9M vs P/E 43, rev $7.55B
Atara Biotherapeutics Inc (ATRA) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ATRA currently screens at market cap $87.1M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ATRA and FAST stock pages for the full models.
Not investment advice.